Oncolytic vesicular stomatitis virus-based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8(+) T-cell functionality.

, , , ,

Journal for immunotherapy of cancer Vol. 8 (1) • Mar 2020

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 32179632

DOI: 10.1136/jitc-2019-000465 [doi]

Publication Year: 2020

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.